您的位置: 首页 > 农业专利 > 详情页

THERAPEUTICS FOR GLYCOGEN STORAGE DISEASE TYPE III
专利权人:
Ultragenyx Pharmaceutical Inc.
发明人:
Kiyoshi TACHIKAWA,Carlos Gustavo PEREZ-GARCIA,Padmanabh CHIVUKULA,Hari Prakash BHASKARAN,Christian W. COBAUGH,Sean Christopher DAUGHERTY
申请号:
US16617431
公开号:
US20200149017A1
申请日:
2018.05.31
申请国别(地区):
US
年份:
2020
代理人:
摘要:
This invention provides a range of translatable polynucleotide and oligomer molecules for expressing a human amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), or a fragment thereof having AGL activity. The polynucleotide and oligomer molecules are expressible to provide the human AGL or a fragment thereof having AGL activity. The molecules can be used as active agents to express an active polypeptide or protein in cells or subjects. The agents can be used in methods for ameliorating, preventing, delaying onset, or treating a disease or condition associated with reduced activity of amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL) in a subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充